SAFC Introduces New Media System
The system is compatible with a wide range of industrial CHO cell lines.
SAFC announced on Apr. 7, 2015 that the company has introduced a new fed-batch medium, EX-CELL Advanced CHO Fed-batch System. The new basal media, available with and without glucose, is said to offer “high titers, robust scalability, and uncompromised protein quality,” according to a statement.
"At SAFC we recognize our customers' needs are constantly changing," said Deb Stutz, director of biopharm marketing at SAFC. "We are delighted to launch this product in response to market needs for new levels of speed and performance, while continuing to provide the confidence of a secure and transparent supply chain."
Fed-batch production processes have improved upstream process titers dramatically in recent years. According to some sources, companies have been able to attain antibody concentrations of up to 10–13 g/L using fed-batch processes. Although batch-fed stainless steel bioreactors remain the preferred choice for the commercial manufacture of therapeutics, according to research by BioPlan Associates, continuous bioprocessing is also emerging as a viable option for upstream activities.
Source: SAFC
Benuvia Granted GMP Certification by Brazil National Health Surveillance Agency
March 14th 2025The certification allows Benuvia to produce pharmaceutical products for companies, either local to Brazil or international, that may be looking for compliant and high-quality production capabilities in the Brazilian pharmaceutical market.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
